Decision making of the p53 network: Death by integration

Journal of Theoretical Biology

Volumn 271, Issue 1, 2011, Pages 205-211

  Li, Zhiyuan ^a,c   Ni, Ming ^a,d   Li, Jikun ^a,e   Zhang, Yuping ^a,f   Ouyang, Qi ^a   Tang, Chao ^a,b  

^a PEKING UNIVERSITY   (China)

^b University of California   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d INSERM   (France)

^e UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell death; Cellular decision making; DNA damage; Modeling; P53 network

Indexed keywords

PROTEIN P53;

APOPTOSIS; CELLULAR AUTOMATON; DECISION MAKING; DNA; MODELING; NUMERICAL MODEL;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL FATE; DNA DAMAGE; DNA REPAIR; MATHEMATICAL MODEL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; UBIQUITINATION; BIOLOGICAL MODEL; CELL NUCLEUS; GENE REGULATORY NETWORK; GENETICS; HUMAN; METABOLISM;

APOPTOSIS; CELL NUCLEUS; DNA DAMAGE; DNA REPAIR; GENE REGULATORY NETWORKS; HUMANS; MITOCHONDRIA; MODELS, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78650386155     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2010.11.041     Document Type: Article

References (47)

1. Aldridge B.B., Burke J.M., Lauffenburger D.A., Sorger P.K. Physicochemical modelling of cell signalling pathways. Nat. Cell Biol. 2006, 8(11):1195-1203.
2. Ashall L., Horton C.A., Nelson D.E., Paszek P., Harper C.V., Sillitoe K., Ryan S., Spiller D.G., Unitt J.F., Broomhead D.S., Kell D.B., Rand D.A., See V., White M.R. Pulsatile stimulation determines timing and specificity of NF-kappaB-dependent transcription. Science 2009, 324(5924):242-246.
3. Bagci E.Z., Vodovotz Y., Billiar T.R., Ermentrout G.B., Bahar I. Bistability in apoptosis: roles of bax, bcl-2, and mitochondrial permeability transition pores. Biophys. J. 2006, 90(5):1546-1559.
4. Bartek J., Lukas J. Pathways governing G1/S transition and their response to DNA damage. FEBS Lett. 2001, 490(3):117-122.
5. Batchelor E., Mock C.S., Bhan I., Loewer A., Lahav G. Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage. Mol. Cell 2008, 30(3):277-289.
6. Blagosklonny M.V. p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect. FASEB J. 2000, 14(13):1901-1907.
7. Braithwaite A.W., Prives C.L. p53: more research and more questions. Cell Death Differ. 2006, 13(6):877-880.
8. Chehab N.H., Malikzay A., Appel M., Halazonetis T.D. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev. 2000, 14(3):278-288.
9. Chipuk J.E. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004, 303(5660):1010-1014.
10. Chipuk J.E., Green D.R. Dissecting p53-dependent apoptosis. Cell Death Differ. 2006, 13(6):994-1002.
11. Ciliberto A., Novak B., Tyson J.J. Steady states and oscillations in the p53/Mdm2 network. Cell Cycle 2005, 4(3):488-493.
12. Cooper G.M. The Cell: A Molecular Approach 1997, ASM Press.
13. Cory S., Adams J.M. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2002, 2(9):647-656.
14. Degterev A., Boyce M., Yuan J. A decade of caspases. Oncogene 2003, 22(53):8543-8567.
15. Fei P., El-Deiry W.S. P53 and radiation responses. Oncogene 2003, 22(37):5774-5783.
16. Gatz S.A., Wiesmuller L. p53 in recombination and repair. Cell Death Differ. 2006, 13(6):1003-1016.
17. Geva-Zatorsky N., Rosenfeld N., Itzkovitz S., Milo R., Sigal A., Dekel E., Yarnitzky T., Liron Y., Polak P., Lahav G., Alon U. Oscillations and variability in the p53 system. Mol. Syst. Biol. 2006, 2.
18. Hamstra D.A., Bhojani M.S., Griffin L.B., Laxman B., Ross B.D., Rehemtulla A. Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging. Cancer Res. 2006, 66(15):7482-7489.
19. Han D., Lerner A.G., Vande Walle L., Upton J.P., Xu W., Hagen A., Backes B.J., Oakes S.A., Papa F.R. IRE1alpha kinase activation modes control alternate endoribonuclease outputs to determine divergent cell fates. Cell 2009, 138(3):562-575.
20. He G., Siddik Z.H., Huang Z., Wang R., Koomen J., Kobayashi R., Khokhar A.R., Kuang J. Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities. Oncogene 2005, 24(18):2929-2943.
21. Hoffmann A., Levchenko A., Scott M.L., Baltimore D. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 2002, 298(5596):1241-1245.
22. Krishna S., Jensen M.H., Sneppen K. Minimal model of spiky oscillations in NF-kappaB signaling. Proc. Natl. Acad. Sci. USA 2006, 103(29):10840-10845.
23. Kuerbitz S.J., Plunkett B.S., Walsh W.V., Kastan M.B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 1992, 89(16):7491-7495.
24. Leu J.I., Dumont P., Hafey M., Murphy M.E., George D.L. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat. Cell Biol. 2004, 6(5):443-450.
25. Lev Bar-Or R., Maya R., Segel L.A., Alon U., Levine A.J., Oren M. Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. Proc. Natl. Acad. Sci. USA 2000, 97(21):11250-11255.
26. Levine A.J., Hu W., Feng Z. The P53 pathway: What questions remain to be explored?. Cell Death Differ. 2006, 13(6):1027-1036.
27. Lin J.H., Li H., Yasumura D., Cohen H.R., Zhang C., Panning B., Shokat K.M., Lavail M.M., Walter P. IRE1 signaling affects cell fate during the unfolded protein response. Science 2007, 318(5852):944-949.
28. Ma L., Wagner J., Rice J.J., Hu W., Levine A.J., Stolovitzky G.A. A plausible model for the digital response of p53 to DNA damage. Proc. Natl. Acad. Sci. USA 2005, 102(40):14266-14271.
29. Maki C.G., Howley P.M. Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol. Cell Biol. 1997, 17(1):355-363.
30. Marchenko N.D., Wolff S., Erster S., Becker K., Moll U.M. Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J. 2007, 26(4):923-934.
31. Marine J.C., Francoz S., Maetens M., Wahl G., Toledo F., Lozano G. Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ. 2006, 13(6):927-934.
32. Massagué J. G1 cell-cycle control and cancer. Nature 2004, 432(7015):298-306.
33. Olsson A., Manzl C., Strasser A., Villunger A. How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?. Cell Death Differ. 2007, 14(9):1561-1575.
34. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., Vogelstein B. A model for p53-induced apoptosis. Nature 1997, 389(6648):300-304.
35. Ramalingam S., Honkanen P., Young L., Shimura T., Austin J., Steeg P.S., Nishizuka S. Quantitative assessment of the p53-Mdm2 feedback loop using protein lysate microarrays. Cancer Res. 2007, 67(13):6247. 6247.
36. Roth J., Dobbelstein M., Freedman D.A., Shenk T., Levine A.J. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 1998, 17(2):554-564.
37. Salmena L., Pandolfi P.P. Changing venues for tumour suppression: balancing destruction and localization by monoubiquitylation. Nat. Rev. Cancer 2007, 7(6):409-413.
38. Speidel D., Helmbold H., Deppert W. Dissection of transcriptional and non-transcriptional p53 activities in the response to genotoxic stress. Oncogene 2006, 25(6):940-953.
39. Strom E., Sathe S., Komarov P.G., Chernova O.B., Pavlovska I., Shyshynova I., Bosykh D.A., Burdelya L.G., Macklis R.M., Skaliter R., Komarova E.A., Gudkov A.V. Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Nat. Chem. Biol. 2006, 2(9):474-479.
40. Tang M., Wahl G.M., Nister M. Explaining the biological activity of transactivation-deficient p53 variants. Nat. Genet. 2006, 38(4):395-396. author reply 396-7.
41. Tiana G., Jensen M.H., Sneppen K. Time delay as a key to apoptosis induction in the p53 network. Eur Phys J. B-Condens. Matter Complex Syst. 2002, 29(1):135-140.
42. Toettcher J.E., Loewer A., Ostheimer G.J., Yaffe M.B., Tidor B., Lahav G. Distinct mechanisms act in concert to mediate cell cycle arrest. Proc. Natl. Acad. Sci. 2009, 106(3):785-790.
43. Tyson J.J. Another turn for p53. Mol. Syst. Biol. 2006, 2(2006):0032.
44. Vaseva, A.V., Moll, U.M., 2008. The mitochondrial p53 pathway. Biochim Biophys Acta.
45. Wagner J., Ma L., Rice J.J., Hu W., Levine A.J., Stolovitzky G.A. p53-Mdm2 loop controlled by a balance of its feedback strength and effective dampening using ATM and delayed feedback. Syst. Biol. (Stevenage) 2005, 152(3):109-118.
46. Yao G., Lee T.J., Mori S., Nevins J.R., You L. A bistable Rb-E2F switch underlies the restriction point. Nat. Cell Biol. 2008, 10(4):476-482.
47. Zhang, X.P., Liu, F., Cheng, Z., Wang, W., 2009. Cell fate decision mediated by p53 pulses. Proc Natl. Acad. Sci. USA.